Announcement
16 Oct 2024
In October 2024, US BARDA awarded USD 32.1 million to Cerus Corporation to support the development of pathogen reduction technology.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
16 Oct 2024
Revocation date:
No revocation date
On 16 October 2024, the Biomedical Advanced Research and Development Authority (BARDA) awarded Cerus Corporation a USD 32.1 million contract to develop the INTERCEPT Blood System for red blood cell...
See all
This state act is not part of any Thread yet.